Imaging Pancreatic Cancer Using Surface-Functionalized Quantum Dots

Jun Qian, Ken-Tye Yong, Indrajit Roy, Tymish Y. Ohulchanskyy, Earl J. Bergey, Hoon Hi Lee, Kenneth M. Tramposch, Sailing He, Anirban Maitra,§ and Paras N. Prasad*
Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, Centre for Optical and Electromagnetic Research, Zhejiang University, Hangzhou 310058, China, and Department of Pathology and Oncology, The Sol Goldman Pancreatic Cancer Research Center, CRB-2, Suite 345, Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, Maryland 21231
J. Phys. Chem. B, 2007, 111 (25), pp 6969–6972
DOI: 10.1021/jp070620n
Publication Date (Web): June 7, 2007
Copyright © 2007 American Chemical Society

Abstract

Abstract Image

In this study, CdSe/CdS/ZnS quantum dots (QDs) were used as optical contrast agent for imaging pancreatic cancer cells in vitro using transferrin and anti-Claudin-4 as targeting ligands. CdSe/CdS/ZnS was chosen because the CdSe/CdS/ZnS QDs have better photoluminescence (PL) efficiency and stability than those of CdSe/ZnS. The transferrin-mediated targeting is demonstrated in both a cell-free coprecipitation assay as well as using in vitro confocal microscopy. Pancreatic cancer specific uptake is also demonstrated using the monoclonal antibody anti-Claudin-4. This targeted QD platform will be further modified for the purpose of developing as an early detection imaging tool for pancreatic cancer.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


History

  • Published In Issue June 28, 2007
  • Received January 24, 2007
    Revised March 30, 2007

Recommend & Share

Related Content

Other ACS content by these authors: